Nano-X Imaging Ltd. Reports Q1 2025 Revenue Increase to $2.8M, Net Loss Widens to $13.2M from $12.2M in Q1 2024

Reuters
06/10
<a href="https://laohu8.com/S/NNOX">Nano-X Imaging Ltd.</a> Reports Q1 2025 Revenue Increase to $2.8M, Net Loss Widens to $13.2M from $12.2M in Q1 2024

Nano-X Imaging Ltd. released its latest financial results, reporting a revenue of $0.2 million from its AI solutions for the recent period, an increase from $97 thousand in the comparable period. The company also reported a gross loss of $1.9 million on a GAAP basis, compared to a $2.0 million gross loss in the previous period. On a non-GAAP basis, the company's AI solutions recorded a gross profit of $81 thousand, improving from $29 thousand in the comparable period. Research and development expenses netted $5.0 million, down from $5.2 million, attributed primarily to a $0.2 million decrease in share-based compensation and a $0.8 million reduction in research and development activity expenses, offset by a $0.8 million decrease in grants received following the completion of the NHSX development project. Sales and marketing expenses for the period amounted to $0.9 million. The company did not provide any specific guidance regarding the number of units expected to be deployed and operational by the end of 2025 or any updates on its research and development, manufacturing, and commercialization activities related to its X-ray source technology and the Nanox.ARC.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nano-X Imaging Ltd. published the original content used to generate this news brief on June 10, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10